Alkermes Plc (NASDAQ:ALKS)
| 18.20 Delayed Data As of 3:59pm ET |  -0.44 / -2.36%Today’s Change | 11.98 Today|||52-Week Range 23.92 | -8.77% Year-to-Date |
Latest ALKS News | Press Releases
No recent news for Alkermes Plc.
Today’s Trading
| Previous close | 18.64 |
| Today’s open | 18.79 |
| Day’s range | 18.14 - 18.85 |
| Volume | 66,248 |
| Average volume (3 months) | 1,297,664 |
| Market cap | $3.0B |
Data as of 3:59pm ET, 03/04/2021
Growth & Valuation
| Earnings growth (last year) | +44.24% |
| Earnings growth (this year) | 0.00% |
| Earnings growth (next 5 years) | +35.58% |
| Revenue growth (last year) | -11.29% |
| P/E ratio | NM |
| Price/Sales | 3.05 |
| Price/Book | 2.84 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OPKOPKO Health Inc | -0.13 | -3.01% |
| PCRXPacira Biosciences I... | -2.18 | -3.14% |
| CORTCorcept Therapeutics... | -0.53 | -2.17% |
| FOLDAmicus Therapeutics ... | -0.30 | -2.81% |
Data as of 4:00pm ET, 03/04/2021
Financials
| Next reporting date | April 29, 2021 |
| EPS forecast (this quarter) | -$0.02 |
| Annual revenue (last year) | $1.0B |
| Annual profit (last year) | -$110.9M |
| Net profit margin | -10.67% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
